GlassScriptPhysician profile
Victoria Webber
NPI 1851066690
$5,216.95
in general payments reported to CMS, 2019-2025
36 companies · $2,147 in 2025
The $2,147 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $1,167 · 2024: $1,630 · 2025: $2,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,273 · Education: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,272.60 |
| Education | $670.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $740.48 | 2022-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $563.21 | 2023-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $396.87 | 2024-2025 | Gemtesa |
| Convatec INC. | $359.82 | 2023-2025 | |
| Endo USA, INC. | $336.58 | 2024-2025 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $311.17 | 2024-2025 | Adstiladrin |
| Immunitybio, INC. | $214.07 | 2024-2025 | |
| Tolmar, INC. | $178.88 | 2025 | Eligard, Jatenzo |
| Medtronic, INC. | $173.39 | 2022 | |
| Antares Pharma, INC. | $159.37 | 2024-2025 | Xyosted |
| Urogen Pharma, INC. | $144.22 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $132.83 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $125.56 | 2024-2025 | |
| Telix Pharmaceuticals | $119.62 | 2023-2025 | Illuccix |
| 180 Medical, INC. | $103.82 | 2024-2025 | Gentlecath, Gentlecath Glide |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $98.45 | 2025 | Provenge |
| Endo Pharmaceuticals INC. | $97.89 | 2023-2024 | Aveed, Xiaflex |
| Abbvie INC. | $94.25 | 2024-2025 | |
| Pfizer INC. | $92.96 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $86.06 | 2023-2025 | Prolaris, Myrisk |
| Dentsply Ih Ab | $81.89 | 2023 | Lofric |
| Astrazeneca Pharmaceuticals LP | $78.28 | 2023-2024 | Lynparza |
| Halozyme INC | $77.50 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $66.59 | 2024-2025 | Bard Urinary Drainage Bag |
| Coloplast Corp | $53.72 | 2025 | |
| Blue Earth Diagnostics | $38.61 | 2025 | Posluma |
| Boston Scientific Corporation | $36.06 | 2023-2025 | Advantage System |
| Teleflex LLC | $35.66 | 2025 | Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $30.93 | 2025 | |
| Agiliti Surgical, INC. | $30.63 | 2023 | Sonablate, Trinity |
| Caris Mpi, INC. | $28.75 | 2025 | Mi Cancer Seek |
| Progenics Pharmaceuticals, INC. | $28.14 | 2023 | Pylarify |
| Bioprotect Medical, INC. | $26.93 | 2024 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $26.52 | 2025 | Keytruda |
| Abc Home Medical Supply, INC. | $24.51 | 2025 | |
| Hollister Incorporated | $22.73 | 2024 | Vapro Plus Pocket |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.